CD79B and bronchopulmonary dysplasia: Downregulation of immune surface marker genes related to T cell maintenance and T and B cell activation (e.g., CD28, CD27, CD7, CD79B, CD83) in cord and/or peripheral blood further supports skewed B and T cell immunity in preterm infants who developed BPD.